StockNews.com assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research note published on Friday. The firm issued a hold rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Stock Down 7.0 % BCLI stock opened at $0.54 on Friday. Brainstorm Cell Therapeutics has a 52-week low of $0.13 and […]
Brainstorm Cell Therapeutics (NASDAQ:BCLI) Now Covered by StockNews.com wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Brokers Set Expectations for Lineage Cell Therapeutics, Inc.'s FY2026 Earnings (NYSEAMERICAN:LCTX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
BriaCell Therapeutics Corp. (NASDAQ:BCTXW – Get Free Report) was the target of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 600 shares, a decrease of 81.3% from the March 15th total of 3,200 shares. Based on an average trading volume of 19,500 shares, […]
StockNews.com began coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, Maxim Group lowered Brainstorm Cell Therapeutics from a buy rating to a hold rating in a research report on Thursday, September […]